1. Home
  2. VALN vs ETON Comparison

VALN vs ETON Comparison

Compare VALN & ETON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Valneva SE

VALN

Valneva SE

N/A

Current Price

$8.71

Market Cap

820.0M

Sector

Health Care

ML Signal

N/A

Logo Eton Pharmaceuticals Inc.

ETON

Eton Pharmaceuticals Inc.

HOLD

Current Price

$16.84

Market Cap

498.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
VALN
ETON
Founded
2012
2017
Country
France
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
820.0M
498.8M
IPO Year
2021
2018

Fundamental Metrics

Financial Performance
Metric
VALN
ETON
Price
$8.71
$16.84
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
3
Target Price
$15.75
$29.67
AVG Volume (30 Days)
19.7K
270.8K
Earning Date
11-20-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$211,089,992.00
$70,316,000.00
Revenue This Year
$5.08
$113.27
Revenue Next Year
$12.53
$36.70
P/E Ratio
N/A
N/A
Revenue Growth
13.48
102.77
52 Week Low
$3.62
$11.09
52 Week High
$12.25
$23.00

Technical Indicators

Market Signals
Indicator
VALN
ETON
Relative Strength Index (RSI) 44.05 49.52
Support Level $8.62 $16.13
Resistance Level $9.10 $17.05
Average True Range (ATR) 0.29 0.76
MACD 0.02 0.16
Stochastic Oscillator 12.25 79.06

Price Performance

Historical Comparison
VALN
ETON

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

About ETON Eton Pharmaceuticals Inc.

Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.

Share on Social Networks: